ArticleBrain communications2025
Abstract read
In one paragraph
Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's Disease.Annals of neurology · 2026Article
- Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- Body Fluid-based Biomarkers for Cognitive Impairment in Parkinson's Disease.Annals of neurosciences · 2026Review
- Discordance of Dopaminergic Dysfunction and Subcortical Atrophy by α-Synuclein Status in Sporadic and Genetic Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- LRRK2 and GBA1 in Lewy body diseases: neuropathological subtypes at opposite ends of a spectrum?Molecular neurodegeneration · 2026Review
- Genetic Associations of Parkinson's Disease Clinical, Pathological, and Data-Driven Subtypes.Genes · 2026Article
- Analysis of α-synuclein seed amplification assay in carriers ofJournal of Parkinson's disease · 2026Article
- Towards biomarker-based diagnosis of Parkinson disease.Nature reviews. Neurology · 2026Review
- Timing of device-aided therapy initiation in Parkinson's disease: reference estimates for healthcare planning and biological heterogeneity.Clinical parkinsonism & related disorders · 2026Article
- GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.Frontiers in neuroscience · 2026Review
- Integrated Biofluid Proteomics Identified Dynamic Functional Biomarkers ofmedRxiv : the preprint server for health sciences · 2025Article
- Alpha-Synuclein Neurobiology in Parkinson's Disease: A Comprehensive Review of Its Role, Mechanisms, and Therapeutic Perspectives.Brain sciences · 2025Review
- Longitudinal decline in striatal DAT binding in LRRK2 Parkinson's disease: connections with CSF α-synuclein seeding activity.Journal of neurology · 2025Article
- Affective phenotypes in heterozygousFrontiers in genetics · 2025Article
Corrections and comments
- Update of
Authors and funding
26 authors.
Lana M ChahineDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
David-Erick LafontantDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA 55848, USA.
Seung Ho ChoiDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA 55848, USA.
Hirotaka IwakiDataTecnica LLC, Washington, DC 20037, USA.
Cornelis BlauwendraatCenter for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD 20892, USA.ORCID https://orcid.org/0000-0001-9358-8111
Andrew B SingletonCenter for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD 20892, USA.
Michael C BrummDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA 55848, USA.
Roy N AlcalayTel Aviv Sourasky Medical Center, 64239 Tel-Aviv, Israel.
Kalpana MerchantDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Kelly Nicole Holohan NudelmanDepartment of Medical and Molecular Genetics, Indiana University, Indianapolis, IN 46202, USA.
Alain DagherMontreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.ORCID https://orcid.org/0000-0002-0945-5779
Andrew VoMontreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Qin TaoMontreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Charles S VenutoDepartment of Neurology, Center for Health and Technology, University of Rochester Medical Center, Rochester, NY 14642,USA.
Karl KieburtzDepartment of Neurology, Center for Health and Technology, University of Rochester Medical Center, Rochester, NY 14642,USA.
Kathleen L PostonDepartment of Neurology, Stanford University School of Medicine, Palo Alto, 94304 CA, USA.
Susan BressmanDepartment of Neurology, Icahn School of Medicine, Mount Sinai Beth Israel, New York City, NY 10029, USA.
Paulina Gonzalez-LatapiDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Brian AvantsInvicro, LLC, Needham, MA 02494, USA.
Christopher CoffeyDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA 55848, USA.
Danna JenningsDenali Therapeutics Inc., South San Francisco, CA 94080, USA.
Eduardo TolosaParkinson's Disease & Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
Andrew SiderowfDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Ken MarekInstitute for Neurodegenerative Disorders, New Haven, CT 06510, USA.
Tatyana SimuniDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Parkinson’s Progression Markers Initiative
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among
Indexed as
alpha-synucleinLRRK2 geneParkinson’s disease
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.